This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tokman, M. G. Articles by Williams, C. L. Search for Related Content PubMed PubMed Citation Articles by Tokman, M. G. Articles by Williams, C. L.

Regulation of Cadherin-mediated Adhesion by the Small GTP-binding Protein Rho in Small Cell Lung Carcinoma Cells¹

Laboratory of Molecular Pharmacology, Guthrie Research Institute, Sayre, Pennsylvania 18840

Metastasis is one of the most important factors responsible for the pathogenesis of small cell lung carcinoma (SCLC). SCLC cells express cadherins, which are homophilic cell-cell adhesion molecules that play an important role in the regulation of metastasis. We present the first evidence that altering the activity of the small GTP-binding protein Rho induces cadherin-mediated adhesion. ADP-ribosylation of Rho upon incubation or electroporation with recombinant C3 exoenzyme induces rapid aggregation and compaction of SCLC cells. Aggregation and compaction induced by C3 exoenzyme are diminished by removal of extracellular Ca²⁺ and by the HECD blocking antibody to E-cadherin but not by antibodies to other adhesion molecules. Altering the activity of Rho by ADP-ribosylation does not alter surface expression of E-cadherin, but it alters G actin content, as indicated by the binding of DNase I. Treatment with cytochalasin D also alters G actin content and increases aggregation and compaction of SCLC cells. These findings implicate Rho in the regulation of cadherin-mediated adhesion and identify Rho as a potential therapeutic target for the control of SCLC metastasis.

¹ This research was supported by NIH Grant CA52471, Department of the Army Grant DAMD 17-94-J-4011, and Office of Naval Research Contract N0014-95-1-1278.

² To whom requests for reprints should be addressed. Phone: (717) 882-4650; Fax: (717) 882-5151; E-mail: cwilliam@inet.guthrie.org.

Received 11/27/96. Accepted 3/19/97.

This article has been cited by other articles:

				S. N. Samarin, A. I. Ivanov, G. Flatau, C. A. Parkos, and A. Nusrat Rho/Rho-associated Kinase-II Signaling Mediates Disassembly of Epithelial Apical Junctions Mol. Biol. Cell, September 1, 2007; 18(9): 3429 - 3439. [Abstract] [Full Text] [PDF]

				T. Gudermann and S. Roelle Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides Endocr. Relat. Cancer, December 1, 2006; 13(4): 1069 - 1084. [Abstract] [Full Text] [PDF]

				J.-w. Cui, W.-h. Li, J. Wang, A.-l. Li, H.-y. Li, H.-x. Wang, K. He, W. Li, L.-h. Kang, M. Yu, et al. Proteomics-based Identification of Human Acute Leukemia Antigens That Induce Humoral Immune Response Mol. Cell. Proteomics, November 1, 2005; 4(11): 1718 - 1724. [Abstract] [Full Text] [PDF]

				T. Ikoma, T. Takahashi, S. Nagano, Y.-M. Li, Y. Ohno, K. Ando, T. Fujiwara, H. Fujiwara, and K.-i. Kosai A Definitive Role of RhoC in Metastasis of Orthotopic Lung Cancer in Mice Clin. Cancer Res., February 1, 2004; 10(3): 1192 - 1200. [Abstract] [Full Text] [PDF]

				W. G. Jiang, G. Watkins, J. Lane, G. H. Cunnick, A. Douglas-Jones, K. Mokbel, and R. E. Mansel Prognostic Value of Rho GTPases and Rho Guanine Nucleotide Dissociation Inhibitors in Human Breast Cancers Clin. Cancer Res., December 15, 2003; 9(17): 6432 - 6440. [Abstract] [Full Text] [PDF]

				D. Strassheim, S. H. Shafer, S. H. Phelps, and C. L. Williams Small Cell Lung Carcinoma Exhibits Greater Phospholipase C-{beta}1 Expression and Edelfosine Resistance Compared with Non-Small Cell Lung Carcinoma Cancer Res., May 1, 2000; 60(10): 2730 - 2736. [Abstract] [Full Text]

				N.-h. Guo, N. S. Templeton, H. Al-Barazi, J. Cashel, J. M. Sipes, H. C. Krutzsch, and D. D. Roberts Thrombospondin-1 Promotes {{alpha}}3{beta}1 Integrin-mediated Adhesion and Neurite-like Outgrowth and Inhibits Proliferation of Small Cell Lung Carcinoma Cells Cancer Res., January 1, 2000; 60(2): 457 - 466. [Abstract] [Full Text]

				D. Strassheim, L. G. May, K. A. Varker, H. L. Puhl, S. H. Phelps, R. A. Porter, R. S. Aronstam, J. D. Noti, and C. L. Williams M3 Muscarinic Acetylcholine Receptors Regulate Cytoplasmic Myosin by a Process Involving RhoA and Requiring Conventional Protein Kinase C Isoforms J. Biol. Chem., June 25, 1999; 274(26): 18675 - 18685. [Abstract] [Full Text] [PDF]

				E. Pötter, C. Bergwitz, and G. Brabant The Cadherin-Catenin System: Implications for Growth and Differentiation of Endocrine Tissues Endocr. Rev., April 1, 1999; 20(2): 207 - 239. [Abstract] [Full Text]

				Y. Zhong, W. M. Brieher, and B. M. Gumbiner Analysis of C-cadherin Regulation during Tissue Morphogenesis with an Activating Antibody J. Cell Biol., January 25, 1999; 144(2): 351 - 359. [Abstract] [Full Text] [PDF]

				R. B. Hazan and L. Norton The Epidermal Growth Factor Receptor Modulates the Interaction of E-cadherin with the Actin Cytoskeleton J. Biol. Chem., April 10, 1998; 273(15): 9078 - 9084. [Abstract] [Full Text] [PDF]

				S Esser, M. Lampugnani, M Corada, E Dejana, and W Risau Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells J. Cell Sci., January 7, 1998; 111(13): 1853 - 1865. [Abstract] [PDF]

				S Levenberg, B. Katz, K. Yamada, and B Geiger Long-range and selective autoregulation of cell-cell or cell-matrix adhesions by cadherin or integrin ligands J. Cell Sci., January 2, 1998; 111(3): 347 - 357. [Abstract] [PDF]